follow-up-pharmacological-pauses-cover

What happens between clinical trials? The role of Follow-Up during pharmacological pauses

Between the end of one clinical trial and the start of another, there’s often a pause in drug administration. Known as the washout period, this phase is medically necessary to eliminate drug residues and assess delayed side effects.

It’s during this time that clinical follow-up becomes essential—for patient safety and to prepare for future study phases.

What is a washout period?

The washout phase is the time during which a study participant does not receive active treatment.

  • According to the FDA, it’s key in crossover trials to avoid treatment carry-over.
  • EMA recommends basing the length of washout on the drug’s half-life and pharmacodynamics.

It ensures a clean baseline for subsequent interventions.

Clinical Follow-Up during washout

Clinical follow-up during this period helps to:

  • Confirm complete drug elimination
  • Detect delayed or long-term side effects
  • Document patient-reported symptoms

AIFA recommends structured clinical assessments, including lab tests and safety evaluations.

Ensuring patient safety before the next trial

Before enrolling in a new study, the participant’s health status must be reassessed:

  • No residual adverse effects
  • Normalized lab values and vital signs
  • No contraindications to the next treatment

AICRO emphasizes the importance of eClinical tools to support eligibility evaluations.

Data collection between trials

The intermediate follow-up period generates valuable real-world data:

  • Vital signs, late AEs, ePRO entries
  • Safety tracking for pharmacovigilance
  • Insights for long-term treatment planning

These data complete the trial picture and enhance scientific validity.

Want to improve how you manage follow-up data?

Patient communication and support

Participants receive clear instructions about:

  • What the washout means
  • Which drugs, foods, or habits to avoid
  • What symptoms to report

Digital tools ensure they stay connected to the site team and compliant with the protocol.

The role of ACTide

Clinical follow-up is not an afterthought—it’s a pillar of continuity in modern research.

With ACTide, teams can:

  • Track post-treatment safety data
  • Monitor washout and re-screening workflows
  • Support patient communication
  • Maintain a full audit trail

Share

C

Information Request

Want more information about our solutions?
Contact us today.



















    Book a Demo Gratis

    See Actide in action — book a free, no-commitment demo and discover how it fits your business in minutes.